Text Version     PDF Version     To Publications Page     To Home Page

To Home Page.

 

 

 

National Drug Intelligence Center.

        

Title:

United States-Canada Border Drug Threat Assessment

 

Publication Date:  December 2001

Document ID: 2002-R0423-001

The United States-Canada Border Drug Threat Assessment is a joint assessment of the common threat posed by the cross-border drug trade. Numerous agencies and departments of both the United States and Canadian governments participated in its preparation.

Your questions, comments, and suggestions for future subjects are welcome at any time.  Addresses are provided at the end of the page.

United States-Canada Border Drug Threat Assessment.

                       

Contents

Foreword

Executive Summary

Acknowledgements

Introduction

Drug Threats
     Marijuana
        Production and Transshipment
        Criminal Groups and Organizations
        Demand
     Cocaine
       
Production and Transshipment
        Criminal Groups and Organizations
        Demand
     Heroin
        Production and Transshipment
        Criminal Groups and Organizations
        Demand
     Precursor Chemicals
       
Production and Transshipment
        Criminal Groups and Organizations
        Demand
   Hashish
       
Production and Transshipment
        Criminal Groups and Organizations
        Demand
   Liquid Hashish
       
Production and Transshipment
        Criminal Groups and Organizations
        Demand

 

   MDMA (Ecstasy)
        Production and Transshipment
        Criminal Groups and Organizations
        Demand
   Methamphetamine
       
Production and Transshipment
        Criminal Groups and Organizations
        Demand
   Other Drugs
   Drug Transportation Across the U.S.-Canada Border
        Land
        Sea
        Air
        Mail

Response to the Situation
   Strategic Goals and Priorities
        United States
        Canada
   Agencies Involved and Budgets
      United States
      Canada
   Overview of Bilateral Cooperation
      Cooperative Agreements and Initiatives
      Large-Scale Cooperative Operations
      Other Bilateral and Multilateral Activities  

Outlook

Sources


List of Maps 

Map 1. Cross-Border Marijuana Distribution
Map 2. Cross-Border Cocaine Distribution
Map 3. Cross-Border Heroin Distribution
Map 4. Cross-Border Precursor Chemical Distribution
Map 5. Cross-Border Hashish and Liquid Hashish Distribution

List of Figures 

Figure 1. Some areas of the U.S.-Canada Border are difficult to monitor.
Figure 2. Canada-produced marijuana exported to the United States typically is high in quality.
Figure 3. An indoor growing operation.
Figure 4. Canada-produced marijuana smuggled in duffle bags.
Figure 5. Powdered cocaine.
Figure 6. Cocaine is frequently transported to the United States aboard commercial vessels.
Figure 7. Clockwise from top: Black tar heroin, brown powdered heroin, and white powdered heroin.
Figure 8. Heroin source regions.
Figure 9. Precursor chemicals.
Figure 10. OMGs are often precursor chemical suppliers.
Figure 11. Hashish.



Figure 12
. The use of containerized cargo is a common hashish transportation method.
Figure 13. Liquid hashish.
Figure 14. MDMA tablets.
Figure 15. Clandestine methamphetamine lab.
Figure 16. OMGs such as the Hells Angels are historically major methamphetamine producers and distributors.
Figure 17. LSD and the prescription drug OxyContin.
Figure 18. The largely unpatrolled border is vulnerable to smugglers such as backpackers.
Figure 19. Pleasure craft are used to smuggle drugs in both directions across the border.
Figure 20. There is a significant level of private air traffic between Canada and the United States.
Figure 21. The Integrated Border Enforcement Team logo.


Foreword

Canada and the United States of America enjoy a political, economic, and social partnership unique in the world. The concrete expression of this is the magnitude of the free flow of people and goods across the border between the two countries. The benefits from this relationship are of critical importance to the day-to-day conduct and the growth of the two nations. This is why the Canadian and United States governments are committed to improving the efficiency of the border and maintaining it as open as possible.

While it is critical to facilitate travel and trade, however, it is also important to ensure that criminal organizations do not profit from this openness. In this regard, the two-way movement of drugs and drug traffickers across the border is a particular mutual concern.

The ability of our countries to counter the threat posed by drugs and drug traffickers depends on the information we possess and the processes in place to use this information effectively. Maintaining the close partnership that exists between United States and Canadian law enforcement authorities is the best strategy to prevent the movement of drugs in both directions and to apprehend drug traffickers. An agreed, coordinated, regional approach is clearly the most effective way to secure our shared border.

During the Fourth Canada-United States Cross-Border Crime Forum, held in Washington, D.C., in June 2000, it was agreed to undertake a joint assessment of the common threat posed by the cross-border drug trade. The enclosed report, "United States-Canada Border Drug Threat Assessment," is the result of that agreement. Numerous agencies involved in fighting drugs participated in its preparation. The National Drug Intelligence Center was critical in the production of the final report.

This assessment has confirmed that illicit drugs are being transported in both directions across the border to meet demand in both our countries. Its preparation has also served to highlight the importance of collecting and sharing data and intelligence on the drug problem to truly understand the magnitude of the threat posed by drugs. Effective strategic decision making depends on this.

The agencies and departments involved in this assessment are committed to addressing this common threat together.


Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov

National Drug Intelligence Center
8201 Greensboro Drive, Suite 1001
McLean, VA 22102-3840

Tel. (703) 556-8970
FAX (703) 556-7807

 

Web Addresses

ADNET:  http://ndicosa 
      DOJ:  http://www.usdoj.gov/ndic/
      LEO:  home.leo.gov/lesig/ndic/ 


To Top     To Contents     To Next Page

To Publications Page     To Home Page


End of page.